Emma Bernsen
Pharmacology and Pharmacogenomics in Pediatric Oncology
Contact details
Our research is focused on two main topics: pharmacogenomics and pharmacokinetic (PK) / pharmacodynamics (PD) modeling. We are studying the role of genetic variants in treatment response and susceptibility to toxicity in pediatric oncology. Also, we want to integrate genetic variants in PK/PD models of classical chemotherapy as well as novel treatments (e.g. immunotherapy) to study their effect on pharmacokinetics and pharmacodynamics in children. With our research we hope to contribute to precision medicine and be able to deliver personalized therapies to children with cancer.
Knowledge & experience
Pharmacology
Pharmacogenomics
Pharmacokinetic/pharmacodynamic modeling
Working experience
2012-2019: Pharmacy BSc/MSc (Utrecht University)
2019-2021: Pharmacist, Princess Máxima Center for Pediatric Oncology
2021-present: PhD Candidate Huitema Group
LinkedIn: https://www.linkedin.com/in/emma-bernsen-05824a82/
ORCID: https://orcid.org/0000-0002-0249-1216
- Publications